Squarepoint Ops LLC Iveric Bio, Inc. Transaction History

Squarepoint Ops LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $5.08 Million - $7.67 Million	193,565 New	193,565 $7.61 Million
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $790,264 - $1.1 Million	-45,839 Reduced 79.49%	11,824 $253,000
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $117,142 - $231,668	12,462 Added 27.57%	57,663 $1.03 Million
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $412,233 - $854,298	45,201 New	45,201 $435,000
Q1 2022 May 16, 2022	SELL	$12.15 - $16.83 $548,633 - $759,958	-45,155 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $560,516 - $761,134	-40,529 Reduced 47.3%	45,155 $755,000
Q3 2021 Nov 15, 2021	SELL	$7.07 - $17.5 $30,563 - $75,652	-4,323 Reduced 4.8%	85,684 $1.39 Million
Q2 2021 Aug 16, 2021	SELL	$5.69 - $7.17 $29,758 - $37,499	-5,230 Reduced 5.49%	90,007 $568,000
Q1 2021 May 17, 2021	BUY	$5.08 - $6.89 $190,403 - $258,244	37,481 Added 64.9%	95,237 $589,000
Q4 2020 Feb 16, 2021	BUY	$5.65 - $7.66 $326,321 - $442,410	57,756 New	57,756 $399,000
Q3 2020 Nov 16, 2020	SELL	$4.01 - $6.29 $143,926 - $225,760	-35,892 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.06 - $6.6 $149,826 - $323,155	-48,963 Reduced 57.7%	35,892 $183,000
Q1 2020 May 15, 2020	BUY	$2.83 - $8.44 $145,207 - $433,056	51,310 Added 152.96%	84,855 $292,000
Q4 2019 Feb 14, 2020	BUY	$0.93 - $8.58 $31,196 - $287,816	33,545 New	33,545 $288,000
Q3 2019 Nov 14, 2019	SELL	$1.09 - $1.29 $13,687 - $16,198	-12,557 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.21 - $1.48 $15,193 - $18,584	12,557 New	12,557 $16,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.